Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

NLRP6 regulates donor T cell activation and acute graft-<i>versus</i>-host disease via ZAP-70-Erk pathway.

Haematologica·2026

Same author

Tocilizumab: From Bench to Bedside - A Comprehensive Review.

Kansas journal of medicine·2026

Same author

MHC class I on target cells regulates CD4<sup>+</sup> T cell-mediated immunity.

Nature immunology·2026

Same author

Author Correction: Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathology.

Nature immunology·2026

Same author

Cognitive Functioning in Vorinostat-Treated Pediatric and Young Adult Patients Over the First 180 Days After Hematopoietic Stem Cell Transplant.

Pediatric blood & cancer·2026

Same author

Mitochondrial complex II orchestrates divergent effects in CD4+ and CD8+ T cells.

The Journal of clinical investigation·2025

Search research articles

Related Experiment Video

Updated: May 29, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Type I-IFNs interfere with GVH responses.

¹University of Michigan Comprehensive Cancer Center, USA.

|September 24, 2011

Summary

Type I interferons (IFNs) can hinder graft-versus-host disease and graft-versus-leukemia responses. This finding is significant for allogeneic stem cell transplantation outcomes.

Area of Science:

Immunology
Hematology
Transplantation

Background:

Type I interferons (IFNs) are crucial in antiviral immunity and regulating autoimmune diseases.
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative therapy for hematologic malignancies.
Graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) are key immune responses following allo-HSCT.

Discussion:

Robb et al. demonstrate that type I-IFNs can negatively modulate both GVHD and GVL responses.
This interference suggests a complex role for type I-IFNs in the post-transplant immune environment.
Understanding this interaction is critical for optimizing allo-HSCT efficacy and safety.

Key Insights:

Type I-IFNs can suppress beneficial anti-leukemia immune responses (GVL).

More Related Videos

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

Related Experiment Videos

Last Updated: May 29, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

Type I-IFNs may also influence the development of GVHD.

The study highlights a potential therapeutic window for modulating type I-IFN activity.

Outlook:

Further research is needed to elucidate the precise mechanisms of type I-IFN interference in allo-HSCT.
Targeting type I-IFN signaling could offer novel strategies to improve GVL effects while managing GVHD.
This work paves the way for developing new immunomodulatory approaches in stem cell transplantation.